Business
Howie's 17+ Years After VesCell(TM): Following Hemostemix's Heart Patients
Calgary, Alberta--(Newsfile Corp. - September 3, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HM...
About this update from Hemostemix Inc
[{"type":"text","content":"Howie's 17+ Years After VesCell(TM): Following Hemostemix's Heart PatientsCalgary, Alberta--(Newsfile Corp. - September 3, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's own) stem cell therapy company offering VesCell™ (ACP-01) to individuals suffering from peripheral arterial disease, chronic limb threatening ischemia, angina, ischemic cardiomyopathy, non ischemic dilated cardiomyopathy, congestive heart failure, and total body ischemia, in Florida under Florida's SB 1768, celebrated the 17+ years of life gained by Howie Lindeman, the results of Howie's VesCell™ treatment in 2008.Florida's law now authorizes the use of VesCell™ in patients with life-threatening or debilitating conditions who have exhausted standard-of-care treatment options. To explain the 17 years he gained from one VesCell™ treatment for ischemic cardiomyopathy, Howie Lindeman, a six-time Grammy Award-winning producer and recording engineer, shared his experience as one of VesCell's™ longest-living recipients (https://youtu.be/xp6SNCOqkDo?si=lBpoURgB1KN0dfjF).Cannot view this video? Visit:https://www.youtube.com/watch?v=xp6SNCOqkDoA Family History and a Life-Changing DecisionAt the age of 39, Howie suffered his first heart attack, marking the beginning of his battle with severe heart disease. As patient treated in 2008, Howie's journey offers a helpful testament to those individuals who have no-option cardiovascular disease.Howie's heart condition was not unexpected, given his family history. Both his father and grandfather succumbed to coronary artery disease. Facing the prospect of open-heart surgery, Howie sought alternatives to the invasive procedure. His research led him to VesCell™, an innovative therapy using a patient's own blood-derived stem cells to restore circulation and improve cardiac function. \"I was determined to find another way,\" Howie shared in his testimonial, reflecting on his decision to pursue VesCell™ over traditional surgery. His choice was informed by a review of clinical data and the therapy's potential to address his ischemic cardiomyopathy as an alternative to open heart surgery.Life Before and After VesCell™Before treatment, Howie described his quality of life as severely diminished, a common experience for those with adva...